A prolactin blood test measures a pituitary hormone best known for starting and maintaining breast milk production. Outside pregnancy and breastfeeding, prolactin usually stays low. When it remains elevated, it can interrupt the hormone signals that trigger ovulation, causing irregular periods, missed periods, infertility, vaginal dryness, or unexpected milk-like nipple discharge. A high result does not automatically mean a pituitary tumor. Stress during the blood draw, sleep, exercise, pregnancy, thyroid disease, kidney disease, medications, and a largely inactive form called macroprolactin can all raise the measured value. Mild elevations often need confirmation under calmer, standardized conditions before imaging or treatment is considered. Interpretation also depends on symptoms, pregnancy status, the laboratory’s range, and whether the elevation is persistent. Very low prolactin is uncommon and usually matters most when milk production is unexpectedly poor after childbirth or when broader pituitary dysfunction is suspected.
- A usual nonpregnant reference range is often below about 20–25 ng/mL, but the reporting laboratory’s interval controls interpretation.
- A mildly high result should usually be repeated after avoiding strenuous exercise, breast stimulation, and a stressful or rushed collection.
- High prolactin can suppress ovulation, leading to longer cycles, missed periods, low estrogen symptoms, and difficulty becoming pregnant.
- Pregnancy, breastfeeding, hypothyroidism, medications, and pituitary conditions are common explanations; PCOS alone should not be assumed to cause the elevation.
- Persistent unexplained elevation may require macroprolactin testing and pituitary MRI, especially with headaches, vision changes, or absent periods.
Table of Contents
- What the Prolactin Test Measures
- Why Prolactin Is Tested in Women
- Preparing for an Accurate Result
- Prolactin Ranges and Result Patterns
- Causes of High and Low Prolactin
- Follow-Up Tests, Imaging, and Treatment
- Fertility, Pregnancy, and Common Questions
What the Prolactin Test Measures
Prolactin is made by lactotroph cells in the anterior pituitary, a small gland beneath the brain. Dopamine from the hypothalamus normally holds prolactin production down. Anything that reduces dopamine’s effect, blocks its receptors, or interrupts the connection between the hypothalamus and pituitary can allow prolactin to rise.
During pregnancy, estrogen stimulates lactotroph growth and prolactin production. After birth, suckling sends nerve signals that promote repeated prolactin release and milk synthesis. Those increases are expected. A result that would be abnormal in a nonpregnant adult can be normal during pregnancy or lactation, so the laboratory must know the clinical setting.
Prolactin also interacts with reproductive hormones. Persistently high levels reduce pulsatile gonadotropin-releasing hormone, or GnRH. The pituitary then releases less effective LH and FSH signaling, ovarian follicles may not mature normally, and ovulation may become infrequent or stop. Estradiol can fall as a result. This explains why hyperprolactinemia may cause missed periods, infertility, vaginal dryness, painful sex, hot flashes, or gradual bone loss when the problem lasts.
A standard test measures total immunoreactive prolactin in serum. Most circulating prolactin is the biologically active monomeric form. Some people have macroprolactin, a large prolactin-immunoglobulin complex that laboratory assays can detect even though it has much less biological activity. Someone with macroprolactinemia may have a flagged result but regular periods and no discharge. Laboratories can use polyethylene glycol precipitation or another method to estimate the active monomeric portion.
Prolactin is usually reported in nanograms per milliliter, written ng/mL, or milli-international units per liter, written mIU/L. Conversion is assay-dependent; a commonly used approximation is 1 ng/mL equals about 21.2 mIU/L. Do not convert a result and compare it with a range from another laboratory without confirming the method.
A single result answers whether prolactin was elevated in that sample. It does not, by itself, identify the cause, prove that ovulation stopped, or diagnose a prolactinoma. The number gains meaning when matched with menstrual history, pregnancy testing, medicines, thyroid and kidney function, symptoms, and repeat measurements.
Why Prolactin Is Tested in Women
Prolactin is commonly included in the evaluation of absent or irregular menstruation. The initial workup usually also excludes pregnancy and checks TSH, because pregnancy and thyroid disease are frequent, treatable explanations for cycle changes. A broader amenorrhea hormone panel may add FSH, LH, and estradiol to show whether ovarian signaling is suppressed or ovarian function is declining.
Testing is reasonable for:
- Periods that have stopped for three months or more without an expected explanation
- Consistently long, unpredictable, or infrequent cycles
- Milk-like nipple discharge outside pregnancy or nursing
- Infertility or evidence that ovulation is not occurring
- Low-estrogen symptoms at an unexpectedly young age
- New headaches, peripheral vision difficulty, or other possible pituitary symptoms
- Follow-up of a known prolactinoma or another pituitary lesion
- Monitoring after a medication change or during dopamine-agonist treatment
- Unexpectedly poor milk production when pituitary injury is a concern
Nipple discharge deserves context. Prolactin-related galactorrhea is usually milky and may come from both breasts with stimulation, but many women with high prolactin have no discharge at all. Bloody, clear, one-sided, or spontaneous discharge from a single duct needs breast evaluation rather than being attributed to prolactin.
Fertility clinicians often order prolactin when cycles are irregular or ovulation appears absent. High prolactin is a potentially reversible reason for infertility, but routine repeated testing is not useful when the first properly collected result is normal and there are no relevant symptoms. Other components of a female infertility blood test panel answer different questions about ovarian function and reserve.
A clinician may also check prolactin when testosterone is low, libido has fallen, or bone density is reduced in the setting of missed periods. These findings can result from prolonged suppression of ovarian estrogen rather than a direct effect of prolactin on every symptom.
Testing after childbirth requires special care. Prolactin rises in pregnancy and fluctuates with feeding, so one random measurement cannot judge milk supply reliably. Low production is more often related to milk removal, latch, retained placental tissue, breast surgery, certain medicines, or maternal illness. Prolactin testing becomes more informative when lactation failure occurs with severe postpartum bleeding, low blood pressure, absent menstruation after weaning, fatigue, or other signs of pituitary hormone loss.
Preparing for an Accurate Result
Prolactin can rise temporarily even when no disease is present. A careful collection reduces false alarms, especially when a previous result was only slightly above the upper limit.
Many laboratories collect the sample at least two to three hours after waking because prolactin increases during sleep and may remain higher shortly after getting up. A fasting sample is not always required, but a clinician may request a morning fasting draw to standardize repeat testing or because other blood tests are being collected. Follow the laboratory’s instructions rather than applying a universal fasting rule.
For about 24 hours before a confirmatory test, avoid intense exercise and unnecessary nipple or breast stimulation. Sex can transiently affect prolactin in some people. On the morning of testing, arrive with enough time to sit quietly for 15–30 minutes. Pain, fear of needles, rushing, and a difficult venipuncture can produce a stress-related increase. When stress is a major concern, a clinic may collect through an indwelling catheter after a rest period or obtain more than one sample.
Bring a complete list of prescriptions, nonprescription products, supplements, and recreational substances. Do not stop an antipsychotic, antidepressant, nausea medicine, opioid, blood-pressure drug, hormonal medicine, or any other treatment on your own. Sudden withdrawal may be dangerous, and the prescriber may prefer repeat testing, a dose adjustment, or a coordinated switch.
Tell the clinician about:
- Pregnancy possibility, recent birth, breastfeeding, or recent weaning
- Date of the last period and usual cycle pattern
- Nipple discharge and whether it is spontaneous or expressed
- Headaches, vision changes, dizziness, or neurological symptoms
- Thyroid, kidney, liver, or pituitary disease
- Chest-wall injury, shingles, surgery, or persistent irritation
- Recent seizures, major illness, or severe physical stress
- Biotin use, because high-dose supplements can interfere with some immunoassays
Cycle day is generally less important for prolactin than for estradiol, FSH, or progesterone. Prolactin may vary modestly across the cycle, but a clinically important persistent elevation is not diagnosed or excluded by choosing one special cycle day.
If the first result is mildly high, repeat under standardized conditions before labeling it chronic hyperprolactinemia. The repeat may be unnecessary when the value is markedly elevated, symptoms are concerning, or there is an obvious urgent reason to investigate. The clinician should also ask whether the laboratory has already screened for macroprolactin or reports monomeric prolactin.
A normal result collected during a quiet morning is reassuring, but symptoms still guide care. For example, missed periods with normal prolactin may require a TSH test, pregnancy testing, FSH and estradiol, or an androgen evaluation rather than repeated prolactin measurements.
Prolactin Ranges and Result Patterns
Reference ranges vary by assay, age, pregnancy status, and laboratory. Many laboratories use an upper limit near 20–25 ng/mL for a nonpregnant woman. Some use lower or higher limits. The result should be read beside the interval printed on the report.
The following ranges are broad interpretive examples, not diagnostic cutoffs:
| Result pattern | Possible interpretation | Typical next step |
|---|---|---|
| Within the laboratory range | Persistent hyperprolactinemia is unlikely | Investigate other causes if symptoms continue |
| Mildly elevated, often about 20–40 ng/mL | Stress, sleep, food, exercise, medicines, hypothyroidism, or macroprolactin may explain it | Repeat carefully and review reversible causes |
| Repeated moderate elevation | Medication effect, pituitary stalk effect, systemic disease, or a small prolactinoma is possible | Check related tests and consider pituitary imaging |
| Marked elevation | A prolactinoma becomes more likely, although pregnancy and some medicines can produce substantial increases | Prompt endocrine assessment and targeted imaging |
| Very low or undetectable | Usually little significance outside lactation; may accompany broader pituitary failure | Assess other pituitary hormones if clinically indicated |
No single number cleanly separates a medication effect from a tumor. Very high concentrations are more strongly associated with a prolactinoma, while a mild increase can occur when another mass compresses the pituitary stalk and blocks dopamine delivery. Tumor size and prolactin level often correlate in true prolactinomas, but assay artifacts and mixed causes can break that pattern.
Two laboratory issues deserve attention:
Macroprolactin
Macroprolactin can make total prolactin appear high while active monomeric prolactin is normal or only slightly raised. It is particularly worth checking when the elevation is persistent but the person has regular periods, no galactorrhea, and no low-estrogen symptoms. Finding macroprolactin can prevent unnecessary MRI scans and medication. It does not mean every symptom should be ignored; the active fraction and the rest of the evaluation still matter.
The high-dose hook effect
Extremely high prolactin can overwhelm some two-site immunoassays and produce a falsely low or only moderately high result. This “hook effect” is uncommon with modern methods but important when MRI shows a very large pituitary mass and the prolactin value seems too low for its size. The laboratory can repeat the assay after diluting the sample.
Trends should be compared using the same laboratory when possible. Switching assays may create an apparent change even when physiology is stable. During treatment, clinicians interpret the prolactin trend together with menstrual recovery, symptoms, tumor size, medication tolerance, and pregnancy plans.
Causes of High and Low Prolactin
High prolactin, called hyperprolactinemia, has physiological, medication-related, systemic, and pituitary causes. Sorting them in that order often avoids unnecessary testing.
Expected and temporary elevations
Pregnancy and breastfeeding produce the largest normal changes. Sleep, exercise, sexual activity, nipple stimulation, physical pain, low blood sugar, seizures, and emotional stress can cause shorter increases. A chest-wall injury, burn, surgery, shingles, or persistent irritation may stimulate nerve pathways similar to suckling.
Medication causes
Dopamine normally restrains prolactin, so dopamine-blocking medicines are frequent causes. Examples include risperidone, paliperidone, amisulpride, haloperidol, and several other antipsychotics. Metoclopramide and domperidone, used for nausea or digestive symptoms in some countries, can raise prolactin substantially. Some antidepressants, opioids, verapamil, methyldopa, and estrogen-containing medicines can contribute.
The size of the increase varies widely. A medication may be essential even when it raises prolactin. The prescribing clinician can weigh symptoms, psychiatric stability, alternatives, dose, and bone or fertility concerns. Adding or switching medication requires coordinated care; treating a laboratory value should never destabilize a serious condition.
Hormonal and systemic disorders
Primary hypothyroidism can raise thyrotropin-releasing hormone, which stimulates prolactin along with TSH. Correcting the thyroid disorder often normalizes prolactin. Kidney failure reduces prolactin clearance, and severe liver disease may alter hormone metabolism. PCOS and hyperprolactinemia can coexist, but a persistent elevation should be investigated rather than automatically attributed to PCOS. An irregular-period hormone panel helps separate these overlapping causes.
Pituitary and hypothalamic causes
A prolactinoma is a benign pituitary adenoma that secretes prolactin. Microprolactinomas are less than 10 mm; macroprolactinomas are 10 mm or larger. Small tumors often present with cycle changes, infertility, or galactorrhea. Larger tumors may also cause headache, loss of peripheral vision, double vision, or deficiencies of other pituitary hormones.
A nonfunctioning pituitary mass, craniopharyngioma, inflammation, trauma, prior radiation, or another lesion can interrupt dopamine delivery through the pituitary stalk. This “stalk effect” usually causes a milder elevation than a large secreting prolactinoma, although numbers overlap.
Low prolactin
A low value is rarely a cause of period or fertility problems by itself. It may be seen after dopamine-agonist treatment or with extensive pituitary damage. The clearest clinical concern is failure to produce milk after childbirth, particularly after severe postpartum hemorrhage that could injure the pituitary. Low prolactin combined with low cortisol, free T4, estradiol, LH, or FSH warrants urgent endocrine assessment because broader pituitary failure can be dangerous.
Follow-Up Tests, Imaging, and Treatment
Follow-up starts by confirming that the elevation is real and persistent. A practical sequence is:
- Exclude pregnancy. hCG testing is essential in anyone who could be pregnant.
- Repeat a mild elevation. Use a rested, standardized collection and verify units and reference range.
- Review medicines and physiological triggers. Include prescriptions, supplements, breastfeeding, recent exercise, and chest stimulation.
- Check TSH and free T4. Treat primary hypothyroidism when present.
- Assess kidney and liver function when indicated. Systemic illness can alter prolactin clearance.
- Request macroprolactin or monomeric prolactin. This is most helpful when symptoms and total prolactin do not agree.
- Obtain pituitary MRI for persistent unexplained hyperprolactinemia. Contrast use and imaging details depend on the clinical situation.
- Evaluate other pituitary hormones and vision when a mass is found. Large lesions may affect cortisol, thyroid, growth hormone, or gonadotropin function.
Formal visual-field testing is appropriate when a lesion approaches the optic pathways or the person reports peripheral vision loss. Sudden severe headache, vomiting, eye-movement problems, fainting, confusion, or abrupt visual loss can indicate pituitary apoplexy, a rare emergency caused by bleeding or infarction in a pituitary tumor. Seek emergency care rather than waiting for an outpatient prolactin repeat.
Treatment targets the cause and the person’s priorities. No treatment may be needed for isolated macroprolactin or a mild asymptomatic elevation with normal active prolactin. Hypothyroidism is treated with thyroid hormone. Medication-induced hyperprolactinemia may improve after a supervised dose change or switch, but the risks of changing an effective psychiatric or gastrointestinal treatment must be considered.
Cabergoline is commonly preferred for symptomatic prolactinomas because it usually lowers prolactin, restores gonadal function, and shrinks the tumor with fewer side effects than bromocriptine. Nausea, dizziness, headache, and low blood pressure can occur, especially early. Starting with a low dose at bedtime or with food may improve tolerance when the prescriber recommends it.
Dopamine agonists can rarely contribute to impulse-control problems such as compulsive gambling, shopping, eating, or sexual behavior. Patients and close family members should know to report a new pattern promptly. Higher cumulative doses used for other conditions raise different heart-valve monitoring questions than the lower doses commonly used for prolactinomas; follow the endocrinologist’s plan rather than arranging tests based only on online thresholds.
Surgery is considered when medication is ineffective, not tolerated, unsuitable, or when rapid decompression is needed. Radiation is rarely required. Follow-up intervals depend on the initial level, tumor size, treatment response, and pregnancy plans. A normal result after therapy does not always mean medication can be stopped immediately.
Fertility, Pregnancy, and Common Questions
High prolactin can impair fertility by preventing regular follicle development and ovulation. Some women stop menstruating; others still bleed but ovulate inconsistently. Restoring prolactin to an appropriate range often brings ovulation back, sometimes before the first period. Anyone who does not want pregnancy should discuss contraception as treatment begins.
Fertility evaluation should not end when high prolactin is found. Age, ovarian reserve, uterine and tubal factors, semen results, and other causes may still affect the chance of conception. A fertility hormone panel can provide complementary information but should be ordered for a defined clinical question rather than as a generic “balance” screen.
Does high prolactin mean I have a prolactinoma?
No. Temporary stress, pregnancy, medicines, hypothyroidism, kidney disease, macroprolactin, and other pituitary-region conditions can raise the result. A prolactinoma becomes more likely when elevation persists, is substantial, and fits the clinical and imaging pattern.
Can PCOS raise prolactin?
PCOS and mild hyperprolactinemia may appear together, but current evaluation treats persistent high prolactin as a separate finding. Confirm the result and investigate medication, thyroid, macroprolactin, and pituitary causes. Do not use high prolactin as a diagnostic feature of PCOS.
Will lowering prolactin restore periods?
Often, when hyperprolactinemia is the reason ovulation stopped. Recovery may take weeks or months and depends on the cause, treatment response, estrogen status, age, and other reproductive conditions. Continued absence of periods after prolactin normalizes needs further evaluation.
Can prolactin be checked while taking birth control?
Yes, but disclose the product. Estrogen-containing contraception can cause a modest rise in some users and also masks the natural cycle pattern. Testing is most useful when symptoms or a prior abnormality create a clear reason; stopping contraception solely to obtain a prolactin result is usually unnecessary unless the clinician advises it.
How is a prolactinoma managed during pregnancy?
Pregnancy planning should involve an endocrinologist. Fertility may return quickly with treatment. The clinician decides whether to stop or continue a dopamine agonist based on tumor size, location, prior response, and symptoms. Routine prolactin measurements during pregnancy are generally not useful because levels normally rise and do not reliably show tumor growth. New severe headache or visual change requires prompt assessment.
Does prolactin need to be “optimal” for fertility?
There is no evidence-based wellness target narrower than the laboratory range for everyone. The aim is to exclude clinically important excess and restore normal reproductive function when prolactin is causing suppression. Repeatedly testing normal values or treating them lower can create side effects without improving fertility.
Keep copies of the original and repeat results, including units, collection time, medications, and the laboratory range. A pattern is far easier to interpret than an isolated number copied without context. Seek urgent care for sudden visual loss, a thunderclap or rapidly worsening headache, confusion, weakness, repeated vomiting, or severe symptoms during pregnancy.
References
- Prolactin Levels: MedlinePlus Medical Test 2025 (Official Test Guide)
- Current evaluation of amenorrhea: a committee opinion 2024 (Committee Opinion)
- Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement 2023 (Consensus Statement)
- Diagnosis of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM) 2024 (Position Statement)
- Treatment of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM) 2024 (Position Statement)
- Prolactinoma Management 2025 (Clinical Review)
Disclaimer
This article provides general education and cannot diagnose the cause of a prolactin result, menstrual change, infertility, nipple discharge, or pituitary symptom. Interpretation requires the laboratory range, pregnancy and breastfeeding status, medication history, repeat testing when appropriate, and clinical assessment. Seek urgent care for sudden severe headache, visual loss, confusion, fainting, or new neurological symptoms.
